These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 27606464)
41. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats. Verma SC; Lan K; Choudhuri T; Robertson ES J Virol; 2006 Apr; 80(7):3445-58. PubMed ID: 16537612 [TBL] [Abstract][Full Text] [Related]
42. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway. Lan K; Kuppers DA; Robertson ES J Virol; 2005 Mar; 79(6):3468-78. PubMed ID: 15731241 [TBL] [Abstract][Full Text] [Related]
43. Identification of Viral and Host Proteins That Interact with Murine Gammaherpesvirus 68 Latency-Associated Nuclear Antigen during Lytic Replication: a Role for Hsc70 in Viral Replication. Salinas E; Byrum SD; Moreland LE; Mackintosh SG; Tackett AJ; Forrest JC J Virol; 2016 Feb; 90(3):1397-413. PubMed ID: 26581985 [TBL] [Abstract][Full Text] [Related]
44. Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency. Mariggiò G; Koch S; Zhang G; Weidner-Glunde M; Rückert J; Kati S; Santag S; Schulz TF PLoS Pathog; 2017 Apr; 13(4):e1006335. PubMed ID: 28430817 [TBL] [Abstract][Full Text] [Related]
45. KSHV LANA acetylation-selective acidic domain reader sequence mediates virus persistence. Juillard F; de Miranda MP; Li S; Franco A; Seixas AF; Liu B; Álvarez ÁL; Tan M; Szymula A; Kaye KM; Simas JP Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22443-22451. PubMed ID: 32820070 [TBL] [Abstract][Full Text] [Related]
46. A unique SUMO-2-interacting motif within LANA is essential for KSHV latency. Cai Q; Cai S; Zhu C; Verma SC; Choi JY; Robertson ES PLoS Pathog; 2013; 9(11):e1003750. PubMed ID: 24278015 [TBL] [Abstract][Full Text] [Related]
47. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824 [TBL] [Abstract][Full Text] [Related]
48. Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter. Cloutier N; Flamand L J Biol Chem; 2010 Mar; 285(10):7208-21. PubMed ID: 20048166 [TBL] [Abstract][Full Text] [Related]
49. An atlas of chromatin landscape in KSHV-infected cells during de novo infection and reactivation. Inagaki T; Kumar A; Komaki S; Nakajima KI; Izumiya Y Virology; 2024 Sep; 597():110146. PubMed ID: 38909515 [TBL] [Abstract][Full Text] [Related]
50. Accumulation of LANA at nuclear matrix fraction is important for Kaposi's sarcoma-associated herpesvirus replication in latency. Ohsaki E; Suzuki T; Karayama M; Ueda K Virus Res; 2009 Jan; 139(1):74-84. PubMed ID: 19027806 [TBL] [Abstract][Full Text] [Related]
51. Hit-to-lead optimization of a latency-associated nuclear antigen inhibitor against Kaposi's sarcoma-associated herpesvirus infections. Kirsch P; Stein SC; Berwanger A; Rinkes J; Jakob V; Schulz TF; Empting M Eur J Med Chem; 2020 Sep; 202():112525. PubMed ID: 32634628 [TBL] [Abstract][Full Text] [Related]
52. A short sequence immediately upstream of the internal repeat elements is critical for KSHV LANA mediated DNA replication and impacts episome persistence. De León Vázquez E; Juillard F; Rosner B; Kaye KM Virology; 2014 Jan; 448():344-55. PubMed ID: 24314665 [TBL] [Abstract][Full Text] [Related]
53. Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma. Staudt MR; Dittmer DP Curr Drug Targets Infect Disord; 2003 Jun; 3(2):129-35. PubMed ID: 12769790 [TBL] [Abstract][Full Text] [Related]
54. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications. Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ mBio; 2018 May; 9(3):. PubMed ID: 29739902 [TBL] [Abstract][Full Text] [Related]
55. Phase separation and DAXX redistribution contribute to LANA nuclear body and KSHV genome dynamics during latency and reactivation. Vladimirova O; De Leo A; Deng Z; Wiedmer A; Hayden J; Lieberman PM PLoS Pathog; 2021 Jan; 17(1):e1009231. PubMed ID: 33471863 [TBL] [Abstract][Full Text] [Related]
56. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors. Veeranna RP; Haque M; Davis DA; Yang M; Yarchoan R J Virol; 2012 Jan; 86(2):1097-108. PubMed ID: 22090111 [TBL] [Abstract][Full Text] [Related]
59. Kaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM. Tadmor H; Greenway M; Ahuja A; Orgil O; Liao G; Ambinder RF; Hayward SD; Shamay M J Virol; 2020 Feb; 94(5):. PubMed ID: 31801865 [TBL] [Abstract][Full Text] [Related]
60. Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues. Sun R; Tan X; Wang X; Wang X; Yang L; Robertson ES; Lan K PLoS Pathog; 2017 Jan; 13(1):e1006167. PubMed ID: 28118409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]